BrainsWay Ltd. announced that favorable insurance policies for its SWIFT Accelerated Deep TMS protocol now cover over 70 million lives in the U.S. This expansion reflects growing acceptance of Deep TMS treatments for major depressive disorder and obsessive-compulsive disorder. The company credits strong clinical data supporting the efficacy and durability of its therapy and continues efforts to educate stakeholders and increase patient access. BrainsWay remains a leader in noninvasive brain stimulation technology with ongoing research and FDA-cleared indications.
BrainsWay's announcement of over 70 million lives covered by favorable Accelerated Deep TMS™ insurance policies provides context for readers. For those following the health sector, here is Pluang's market snapshot as of Oct 13, 2026 18:02 WIB: out of 128 priced US health stocks, 78 rose and 41 fell. Notable movers include BioNTech SE (BNTX) at USD 93.03 with a 1-day change of -2.93%, Heron Therapeutics Inc (HRTX) at USD 0.40 down 2.79% with a Pluang order activity of 76% Sell / 24% Buy, and Johnson & Johnson (JNJ) at USD 256.82 down 2.62% with 84% Sell / 16% Buy activity. Typical hold times range from 36 to 129 days.
Existing-home sales in the U.S. increased by 1.5% month-over-month in September but declined 2.2% compared to the previous year, according to the National Association of Realtors. Sales rose in the South and West regions but fell in the Northeast and...
Columbus Marketing Experts, a digital marketing agency in Hilliard, Ohio, is expanding its local SEO services across Columbus to help service businesses improve their visibility on Google Search and Google Maps. The expansion aims to enhance local di...
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
Nvidia CEO Jensen Huang has reaffirmed his forecast that global spending on AI infrastructure will grow significantly, reaching between $3 trillion and $4 trillion by 2030. This projection highlights the massive potential and ongoing investment in AI...
